A small rise in CEA is sensitive for recurrence after surgery for colorectal cancer

Colorectal Disease

Volumn 9, Issue 6, 2007, Pages 527-531

  Irvine, Tracey ^a   Scott, M ^a   Clark, C I ^a  

^a WHITTINGTON HOSPITAL   (United Kingdom)

Author keywords

Carcinoembrionic antigen; Colorectal cancer; Recurrence

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; COLORECTAL CANCER; COLORECTAL SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 34250716337     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2007.01176.x     Document Type: Article

References (31)

1. Gold P, Freedman SO. Demonstration of tumour specific antigen in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 1965; 121: 439-62.
2. Barillari P, Bolognese A, Chirletti P, Cardi M, Sammartino P, Stipa V. Role of CEA, TPA, and Ca19-9 in the early detection of localized and diffuse recurrent rectal cancer. Dis Colon Rectum 1992; 35: 471-6.
3. Moertal CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen C. An Evaluation of the Carcinoembryonic Antigen (CEA) Test for monitoring patients with resected colon cancer. JAMA 1993; 270: 943-7.
4. Li Destri G, Greco S, Rinzivillo C, Racalbuto A, Curreri R, Di Cataldo A. Monitoring carcinoembryonic antigen in colorectal cancer: Is it still useful? Surgery Today 1998; 28: 1233-6.
5. McMillan DC, Wotherspoon HA, Fearon KCH, Sturgeon C, Cooke TG, McArdle CS. A prospective study of tumour recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am J Surg 1995; 170: 319-21.
6. Anonymous. 1997 update of recommendations for the use of breast and tumour markers in breast and colorectal cancer. Adopted on November 7, 1997 by the American Society of Clinical Oncology. J Clin Oncol 1998; 16: 793-5.
7. McArdle C. ABC of colorectal cancer. Effectiveness of follow up. BMJ 2000; 321: 1332-5.
8. Northover J. Carcinoembryonic antigen and recurrent colorectal cancer. Gut 1986; 27: 117-22.
9. Nelson RL. Postoperative evaluation of patients with colorectal cancer. Semin Oncol 1995; 22: 488.
10. Schoemaker D, Black R, Giles L, Toouli J. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology 1998; 114: 7-14.
11. Kjeldsen BJ, Kronborg O, Fenger C, Jorgensen OD. A prospective randomised study of follow-up after radical surgery for colorectal cancer. Br J Surg 1997; 84: 666-9.
12. Bruinvels DJ, Stiggelbout AM, Kievit J, Van Houwelingen HC, Habbema JDF, Van De Velde JH. Follow-up of patients with colorectal cancer. Ann Surg 1994; 219: 174-82.
13. Makela JT, Laitinen SO, Kairaluoma MI. Five-year follow-up after radical surgery for colorectal cancer. Arch Surg 1995; 130: 1062-7.
14. Graham RA, Wang S, Catalano PJ, Haller DG. Postsurgical surveillance of colon cancer - preliminary cost analysis of physician examination, carcinoembryonic antigen testing, chest x-ray and colonoscopy. Ann Surg 1998; 228: 59-63.
15. Wichmann MW, Lau-Werner U, Muller C et al. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer. Anticancer Res 2000; 20: 4953-6.
16. Kelly CJ, Daly JM. Colorectal cancer: Principles of postoperative follow-up. Cancer 1992; 70: 1397-408.
17. Schiessel R, Wunderlich M, Herbst F. Local recurrence of colorectal cancer: Effect of early detection and aggressive surgery. Br J Surg 1986; 73: 342-4.
18. Fletcher RH. CEA Monitoring after surgery for colorectal cancer. When is the evidence sufficient? JAMA 1993; 270: 987-8.
19. Berman JM, Cheung RJ, Weinberg DS. Surveillance after colorectal cancer resection. Lancet 2000; 355: 395-9.
20. Rockall TA, McDonald PJ. Carcinoembryonic antigen: Its value in the follow-up of patients with colorectal cancer. Int J Colorectal Dis 1999; 14: 73-7.
21. Ohlsson B, Breland U, Ekberg H, Graffner H, Tranberg KG. Follow-up after curative surgery for colorectal carcinoma. Dis Colon Rectum 1995; 38: 619-26.
22. Northover JMA. Carcinoembryonic antigen and recurrent colorectal cancer. Br J Surg 1985; 72: S45-6.
23. Fletcher RH. Carcinoembryonic antigen. Ann Intern Med 1986; 104: 66-73.
24. Castells A, Bessa X, Daniels M et al. Value of postoperative surveillance after radical surgery for colorectal cancer. Dis Colon Rectum 1998; 41: 714-23.
25. Bergamaschi R, Arnaud J-P. Routine compared with nonscheduled follow-up of patients with 'curative' surgery for colorectal cancer. Ann Surg Oncol 1996; 3: 464-9.
26. Engaras B. Individual cutoff levels of carcinoembryonic antigen and CA 242 indicate recurrence of colorectal cancer with high sensitivity. Dis Colon Rectum 2003; 46: 313-21.
27. Staab HJ, Anderer FA, Stumpf E, Fischer R. Slope analysis of the postoperative CEA time course and its possible application as an aid in diagnosis of disease progression in gastrointestinal cancer. Am J Surg 1978; 136: 322-7.
28. Bucci L, Benassai G, Santoro GA. Second look in colorectal surgery. Dis Colon Rectum 1994; 37: S123-6.
29. Minton JP, Hoehn IL, Gerber DM et al. Results of a 400-patient carcinoembryonic antigen second look colorectal cancer study. Cancer 1985; 55: 1284-90.
30. Schneebaum S, Arnold MW, Young D et al. Role of carcinoembryonic antigen in predicting resectability of recurrent colorectal cancer. Dis Colon Rectum 1993; 36: 810-5.
31. Vauthey JN, Dudrick PS, Scott Lind D, Copeland EM. Management of recurrent colorectal cancer: Another look at carcinoembryonic antigen-detected recurrence. Dig Dis 1996; 14: 5-13.